Join
Live feed
·
PRReleasevia Quantisnow
Kiora Pharmaceuticals Inc. logo

Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model

ByQuantisnow·Wall Street's wire, on your screen.
KPRX· Kiora Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KPRX (Kiora Pharmaceuticals Inc.) and more on Quantisnow.